Diisopropyl fluorophosphate

Jump to navigation Jump to search
Diisopropyl fluorophosphate
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC6H14FO3P
Molar mass184.146 g/mol
3D model (JSmol)
Melting point−82 °C (−115.6 °F)
Boiling point46 °C (114.8 °F) 5 mmHg

WikiDoc Resources for Diisopropyl fluorophosphate

Articles

Most recent articles on Diisopropyl fluorophosphate

Most cited articles on Diisopropyl fluorophosphate

Review articles on Diisopropyl fluorophosphate

Articles on Diisopropyl fluorophosphate in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Diisopropyl fluorophosphate

Images of Diisopropyl fluorophosphate

Photos of Diisopropyl fluorophosphate

Podcasts & MP3s on Diisopropyl fluorophosphate

Videos on Diisopropyl fluorophosphate

Evidence Based Medicine

Cochrane Collaboration on Diisopropyl fluorophosphate

Bandolier on Diisopropyl fluorophosphate

TRIP on Diisopropyl fluorophosphate

Clinical Trials

Ongoing Trials on Diisopropyl fluorophosphate at Clinical Trials.gov

Trial results on Diisopropyl fluorophosphate

Clinical Trials on Diisopropyl fluorophosphate at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Diisopropyl fluorophosphate

NICE Guidance on Diisopropyl fluorophosphate

NHS PRODIGY Guidance

FDA on Diisopropyl fluorophosphate

CDC on Diisopropyl fluorophosphate

Books

Books on Diisopropyl fluorophosphate

News

Diisopropyl fluorophosphate in the news

Be alerted to news on Diisopropyl fluorophosphate

News trends on Diisopropyl fluorophosphate

Commentary

Blogs on Diisopropyl fluorophosphate

Definitions

Definitions of Diisopropyl fluorophosphate

Patient Resources / Community

Patient resources on Diisopropyl fluorophosphate

Discussion groups on Diisopropyl fluorophosphate

Patient Handouts on Diisopropyl fluorophosphate

Directions to Hospitals Treating Diisopropyl fluorophosphate

Risk calculators and risk factors for Diisopropyl fluorophosphate

Healthcare Provider Resources

Symptoms of Diisopropyl fluorophosphate

Causes & Risk Factors for Diisopropyl fluorophosphate

Diagnostic studies for Diisopropyl fluorophosphate

Treatment of Diisopropyl fluorophosphate

Continuing Medical Education (CME)

CME Programs on Diisopropyl fluorophosphate

International

Diisopropyl fluorophosphate en Espanol

Diisopropyl fluorophosphate en Francais

Business

Diisopropyl fluorophosphate in the Marketplace

Patents on Diisopropyl fluorophosphate

Experimental / Informatics

List of terms related to Diisopropyl fluorophosphate

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Diisopropyl fluorophosphate (DFP, diisopropyl phosphorofluoridate) is an oily, colorless or faint yellow liquid with the chemical formula C6H14FO3P. It is used in medicine and as an organophosphate insecticide. It is stable, but undergoes hydrolysis when subjected to moisture, producing hydrofluoric acid. It is a structural analog of sarin.

It is known also under names Demecarium, Difluorophate, Diflupyl, Diflurphate, Dyflos, Dyphlos, Fluoropropyl, Fluropryl, Fluostigmine, Humorsol, isofluorophate, isofluorphate, Neoglaucit, PF-3, PF3, T-1703, TL 466, and others.

Uses in medicine

Diisopropyl fluorophosphate (closely related to demecarium bromide) has been used in ophthalmology as a miotic agent in treatment of chronic glaucoma, as a miotic in veterinary medicine, and as an experimental agent in neuroscience because of its acetylcholinesterase inhibitory properties and ability to induce delayed peripheral neuropathy. It is known as fluostigmine and Dyflos in such uses.

Uses as toxin

The marked toxicity of esters of monofluorophosphoric acid was discovered in 1932, when Willy Lange and his PhD student Gerda von Krueger prepared the methyl, ethyl, n-propyl, and n-butyl esters and incidentally experienced their toxic effects. Another homologue of this series of esters, Diisopropyl fluorophosphate, was developed by British scientist Bernard Charles Saunders. On his search for compounds to be used as chemical warfare agents, Saunders was inspired by the report by Lange und Krueger and decided to prepare the new homologue which he labeled PF-3. It was much less deadly than tabun or sarin, however it could be mixed with mustard gas, forming a more potent mixture with significantly lower melting point, resulting in an agent suitable for use in cold weather. In military research, due to its physical and chemical similarities and comparatively low toxicity, it is used as a simulant of G-agents (GA, GB, GD, GF).

Diisopropyl fluorophosphate is a very potent neurotoxin. Its LD50 for rats is 1.3 mg/kg. It combines with the amino acid serine at the active site of the enzyme acetylcholinesterase, an enzyme that deactivates the neurotransmitter acetylcholine. Neurotransmitters are needed to continue the passage of nerve impulses from one neuron to another across the synapse. Once the impulse has been transmitted, acetylcholinesterase functions to deactivate the acetylcholine almost immediately by breaking it down. If the enzyme is inhibited, acetylcholine accumulates and nerve impulses cannot be stopped, causing prolonged muscle contraction. Paralysis occurs and death may result since the respiratory muscles are affected.

Sources


External links

Template:Antiglaucoma preparations and miotics

de:Diisopropylfluorophosphat